Open Access Pharmacovigilance Journals

In spite of US FDA and European agencies guidelines for marketing of optically active (homochiral) drugs, the racemic mixtures of chiral drugs are being sold and prescribed by clinicians in most of the Asian and African countries, resulting into some diseases and various side effects in human beings. It is a matter of great concern for all of us to have well developed, prosperous and healthy world. Therefore, there is a great need to design and develop economic, effective and selective methods of drugs. Imran Ali, Chiral drugs development: Safe medication for future.

• Share this page
• 
• 
• 
• 
• 
• 

Last date updated on June, 2014